Method of pre-treating sample for measuring saccharified amine and method of measuring saccharified amine

Abstract

The present invention provides a method of pretreating a sample containing a glycated amine as an analyte, thereby enabling highly reliable measurement of a glycated amine. A glycated amino acid in the sample is degraded by causing a fructosyl amino acid oxidase (FAOD) to act thereon, and thereafter, a FAOD further is caused to act on the glycated amine as the analyte in the sample to cause a redox reaction. The amount of the glycated amine is determined by measuring the redox reaction. The substrate specificity of the FAOD caused to act on the glycated amino acid may be either the same as or different from that of the FAOD caused to act on the glycated amine. When using the same FAOD, a FAOD is caused to act on the glycated amino acid to degrade it, and thereafter, the sample is treated with a protease to inactivate the FAOD and also to degrade the glycated amine. Then, the same FAOD further is added so that the FAOD acts on the degradation product obtained to cause a redox reaction, and the redox reaction is measured.

1. A method of pretreating a sample containing a glycated amine as an analyte, comprising:
 pretreating said sample by adding a first fructosyl amino acid oxidase to said sample to act on a glycated amino acid or a glycated peptide present in the sample other than the analyte so as to remove the glycated amino acid or the glycated peptide by degrading it; 
 adding a second fructosyl amino acid oxidase to said sample after the pretreatment to react with the analyte or the degradation product of the analyte to form hydrogen peroxide; and 
 measuring the amount of hydrogen peroxide by a redox reaction to determine the amount of the analyte. 
 
     
     
       2. The method according to  claim 1 , wherein the first fructosyl amino acid oxidase used in the pretreating step has a substrate specificity different from that of the second fructosyl amino acid oxidase that reacts with the analyte or the degradation product of the analyte. 
     
     
       3. The method according to  claim 2 , wherein the first fructosyl amino acid oxidase used in the pretreating step is specific for a glycated α-amino group, and the second fructosyl amino acid oxidase that reacts with the analyte or the degradation product of the analyte is specific for a glycated α-amino group and a glycated side chain of an amino acid residue. 
     
     
       4. The method according to  claim 3 , wherein the glycated amino acid present in the sample other than the analyte is a glycated amino acid having a glycated α-amino group, and the analyte is a glycated protein or a glycated peptide having a glycated α-amino group and a glycated side chain of an amino acid residue. 
     
     
       5. The method according to  claim 2 , further comprising:
 degrading the analyte with a protease to give a degradation product of the analyte either before or after the pretreating step. 
 
     
     
       6. The method according to  claim 5 , wherein the protease is at least one protease selected from the group consisting of metalloproteinases, bromelain, papain, trypsin, proteinase K, subtilisin, and aminopeptidase. 
     
     
       7. The method according to  claim 6 , wherein the protease is at least one protease that degrades a glycated hemoglobin selectively and is selected from the group consisting of metalloproteinases, bromelain, papain, trypsin derived from porcine pancreas, and protease derived from Bacillus subtilis. 
     
     
       8. The method according to  claim 1 , further comprising:
 degrading the analyte with a protease to give a degradation product of the analyte after the pretreating step, 
 wherein the second fructosyl amino acid oxidase that reacts with the analyte or the degradation product of the analyte is same as the first fructosyl amino acid used in the pretreating step. 
 
     
     
       9. The method according to  claim 8 , wherein the first fructosyl amino acid oxidase used in the pretreating step is inactivated with the protease. 
     
     
       10. The method according to  claim 8 , wherein the first fructosyl amino acid oxidase (A) used in the pretreating step and the second fructosyl amino acid oxidase (B) that reacts with the analyte or the degradation product of the analyte are added respectively to the sample so that a ratio (activity ratio A:B) of the first fructosyl amino acid oxidase (A) to the second fructosyl amino acid oxidase (B) is in a range from 1:10 to 1:50,000. 
     
     
       11. The method according to  claim 8 , wherein a glycation site of the glycated amino acid or a glycated peptide is an α-amino group, the analyte is a glycated protein, and a glycation site of the protein is an α-amino group. 
     
     
       12. The method according to  claim 8 , wherein the protease is at least one protease selected from the group consisting of metalloproteinases, bromelain, papain, trypsin, proteinase K, subtilisin, and aminopeptidase. 
     
     
       13. The method according to  claim 12 , wherein the protease is at least one protease that degrades a glycated hemoglobin selectively and is selected from the group consisting of metalloproteinases bromelain, papain, trypsin derived from porcine pancreas, and protease derived from Bacillus subtilis. 
     
     
       14. The method according to  claim 1 , wherein the glycated amine is at least one substance selected from the group consisting of glycated amino acids, glycated peptides, and glycated proteins. 
     
     
       15. The method according to  claim 14 , wherein the glycated proteins are glycated hemoglobins. 
     
     
       16. The method according to  claim 1 , wherein the sample is at least one biological sample selected from the group consisting of whole blood, plasma, serum, blood cells, urine, and spinal fluid. 
     
     
       17. The method according to  claim 16 , wherein the sample is a whole blood sample collected from a patient after being put on an intravenous drip. 
     
     
       18. The method according to  claim 1 , wherein the glycated amino acid present in the sample other than the glycated amine as the analyte includes an exogenous glycated amino acid. 
     
     
       19. A method of measuring an amount of glycated protein in a sample, comprising:
 adding fructosyl amino acid oxidase to said sample so as to remove any glycated amino acid or glycated peptide present in said sample other than the glycated protein;   subsequently degrading the glycated protein by adding a protease to said sample to form a degradation product of the glycated protein; and   measuring the amount of hydrogen peroxide produced by a redox reaction between the fructosyl amino acid oxidase and the degradation product of the glycated protein to determine the amount of the glycated protein.   
     
     
       20. The method according to claim 19, wherein the glycated amino acid present in the sample other than the glycated protein is a glycated amino acid having a glycated α-amino group, and wherein the glycated protein has a glycated α-amino group and a glycated side chain of an amino acid residue. 
     
     
       21. The method according to claim 20, wherein the protease is at least one protease selected from the group consisting of metalloproteinases, bromelain, papain, trypsin, proteinase K, subtilisin, and aminopeptidase. 
     
     
       22. The method according to claim 21, wherein the protease is at least one protease that degrades a glycated hemoglobin selectively and is selected from the group consisting of metalloproteinases, bromelain, papain, trypsin derived from porcine pancreas, and protease derived from Bacillus subtilis. 
     
     
       23. The method according to claim 19, wherein the glycated protein is glycated hemoglobin. 
     
     
       24. The method according to claim 19, wherein the sample is at least one biological sample selected from the group consisting of whole blood, plasma, serum and blood cells. 
     
     
       25. The method according to claim 24, wherein the sample is a whole blood sample collected from a patient after being put on an intravenous drip. 
     
     
       26. The method according to claim 19, wherein the glycated amino acid present in the sample other than the glycated protein includes an exogenous glycated amino acid. 
     
     
       27. A method of measuring an amount of glycated protein in a sample, comprising:
 removing a glycated amino acid or a glycated peptide present in said sample other than the glycated protein by adding fructosyl amino acid oxidase to said sample; followed by   adding a protease to said sample to degrade the glycated protein, which degraded glycated protein then reacts with the fructosyl amino acid oxidase to form hydrogen peroxide; and   measuring the amount of the hydrogen peroxide to determine the amount of the glycated protein.   
     
     
       28. The method according to claim 27, wherein the glycated amino acid present in the sample other than the glycated protein is a glycated amino acid having a glycated α-amino group, and wherein the glycated protein has a glycated α-amino group and a glycated side chain of an amino acid residue. 
     
     
       29. The method according to claim 28, wherein the protease is at least one protease selected from the group consisting of metalloproteinases, bromelain, papain, trypsin, proteinase K, subtilisin, and aminopeptidase. 
     
     
       30. The method according to claim 29, wherein the protease is at least one protease that degrades a glycated hemoglobin selectively and is selected from the group consisting of metalloproteinases, bromelain, papain, trypsin derived from porcine pancreas, and protease derived from Bacillus subtilis. 
     
     
       31. The method according to claim 27, wherein the glycated protein is glycated hemoglobin. 
     
     
       32. The method according to claim 27, wherein the sample is at least one biological sample selected from the group consisting of whole blood, plasma, serum and blood cells. 
     
     
       33. The method according to claim 32, wherein the sample is a whole blood sample collected from a patient after being put on an intravenous drip. 
     
     
       34. The method according to claim 27, wherein the glycated amino acid present in the sample other than the glycated protein includes an exogenous glycated amino acid. 
     
     
       35. A method of pretreating a sample containing a glycated protein as an analyte, comprising:
 adding fructosyl amino acid oxidase to said sample to act on a glycated amino acid or a glycated peptide present in the sample other than the analyte so as to remove the glycated amino acid or the glycated peptide by degrading it prior to adding a protease to said sample,   wherein the fructosyl amino acid oxidase is at least one of a fructosyl amino acid oxidase specific for a glycated α-amino group (FAOD-α) and a fructosyl amino acid oxidase specific for both a glycated α-amino group and a glycated amino group in a side chain of an amino acid residue (FAOD-αS),   wherein the glycated protein is a glycated hemoglobin or a glycated albumin, and   wherein the sample is at least one of a plasma sample, a serum sample, or a hemolyzed sample which is prepared by hemolysis of whole blood itself or erythrocytes separated from whole blood.   
     
     
       36. The method according to claim 35, wherein the sample is a plasma sample. 
     
     
       37. The method according to claim 35, wherein the sample is a serum sample. 
     
     
       38. The method according to claim 35, wherein the fructosyl amino acid oxidase is a fructosyl amino acid oxidase specific for a glycated α-amino group (FAOD-α). 
     
     
       39. The method according to claim 35, wherein the fructosyl amino acid oxidase is a fructosyl amino acid oxidase specific for both a glycated α-amino group and a glycated amino group in a side chain of an amino acid residue (FAOD-αS).